Cytokinetics, IncorporatedCYTKNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank90
3Y CAGR+126.4%
Year-over-Year Change
Year-over-year net income growth rate
3Y CAGR
+126.4%/yr
vs -22.4%/yr prior
Acceleration
+148.9pp
Accelerating
Percentile
P90
Near historical high
vs 3Y Ago
11.6x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 40.22% |
| Q3 2025 | -127.86% |
| Q2 2025 | 16.73% |
| Q1 2025 | -7.57% |
| Q4 2024 | 6.56% |
| Q3 2024 | -12.02% |
| Q2 2024 | -5.66% |
| Q1 2024 | 0.92% |
| Q4 2023 | -5.77% |
| Q3 2023 | -0.61% |
| Q2 2023 | 2.02% |
| Q1 2023 | 4.43% |
| Q4 2022 | 3.46% |
| Q3 2022 | -618.01% |
| Q2 2022 | 77.84% |
| Q1 2022 | -192.59% |
| Q4 2021 | 59.82% |
| Q3 2021 | -23.61% |
| Q2 2021 | -30.68% |
| Q1 2021 | -7.23% |
| Q4 2020 | -1283.62% |
| Q3 2020 | 92.21% |
| Q2 2020 | -3.49% |
| Q1 2020 | -28.61% |
| Q4 2019 | -3.61% |
| Q3 2019 | 7.91% |
| Q2 2019 | -9.35% |
| Q1 2019 | -10.95% |
| Q4 2018 | -20.22% |
| Q3 2018 | 20.01% |
| Q2 2018 | 9.11% |
| Q1 2018 | 25.20% |
| Q4 2017 | -25.12% |
| Q3 2017 | -11.27% |
| Q2 2017 | -12.43% |
| Q1 2017 | -461.42% |
| Q4 2016 | -78.55% |
| Q3 2016 | 387.33% |
| Q2 2016 | 6.78% |
| Q1 2016 | -34.96% |